Does leukocyte-poor or leukocyte-rich platelet-rich plasma applied with biopolymers have superiority to conventional platelet-rich plasma applications on chondrocyte proliferation?
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.